Hannah Thomasy, PhD
Hannah joined Drug Discovery News as an assistant editor in 2022. She earned her PhD in neuroscience from the University of Washington in 2017 and completed the Dalla Lana Fellowship in Global Journalism in 2020. Her work has appeared in The New York Times, Undark, and New Scientist. She enjoys playing soccer and hiking and hopes to be a contestant on The Great Canadian Baking Show one day.
Articles by Hannah Thomasy, PhD
| 10+ min read
Scientists identified specific genes that confer protection or vulnerability to various infections, pointing the way to new treatments.
| 10 min read
Researchers explore the role of forgetting in normal brain function and as a therapeutic target for fear-related disorders.
| 10+ min read
From reducing prion protein to fighting neuroinflammation, researchers try different techniques to combat deadly prion diseases.
| 5 min read
Isabelle Mansuy explores how life experiences alter the epigenome of an organism and its descendants.
| 10+ min read
Negative childhood experiences can leave epigenetic scars that haunt organisms for life.
| 2 min read
A dementia-associated tau mutation promotes unusual clustering of Fyn, a protein important for learning and memory.
| 10+ min read
For decades, treatment options for sickle cell disease have been extremely limited. Soon, gene therapies and a host of pharmaceuticals could alleviate the immense burden of this disease.
| 6 min read
Emily Mevers investigates the compounds produced by millipedes that may inspire the medicines of the future.
| 2 min read
From green fluorescent protein to polymerase chain reaction, many basic science discoveries fueled important advances in biomedicine.
| 9 min read
Cell therapies derived from stem cells could one day prevent vision loss or even restore sight in retinal degenerative disease.
| 4 min read
Bioengineer Linda Griffith creates tissue models to figure out what causes endometriosis and how to treat it.
| 4 min read
Data from a highly resilient individual guided researchers to new potential therapeutic targets.
| 10 min read
A new form of brain stimulation treatment that responds to a patient’s brain activity could be life changing for people with neurological and psychiatric disorders.
| 9 min read
With childhood peanut allergies on the rise, scientists itch to find ways to prevent deadly reactions to this ubiquitous food.
| 10 min read
People with myalgic encephalomyelitis/chronic fatigue syndrome can wait years for diagnoses; biomolecular tests are finally in development.
Page 1 of 2 - 28 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Getting to the heart of drug safety testing
High throughput optical scanning enhances cardiac ion channel analysis for safer drug development.
Harnessing CRISPR-Cas9: Knocking out genes in myeloid cells
Explore the applications of CRISPR-Cas9 technology in therapeutic development for Alzheimer’s disease.
Harnessing liver-on-a-chip models for drug safety
Discover how researchers leverage microphysiological systems in toxicology studies.
